A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT03926169 · COMPLETED
Trial details
- NCT number
- NCT03926169
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2021-02-02
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.